thiazolidines has been researched along with Diabetes Mellitus, Type 1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, F; Cheng, X; Hu, Y; Rao, J; Shen, G; Wang, X; Yang, C; Yang, S | 1 |
| Hattori, T; Kanai, K; Kuwabara, S; Misawa, S; Nakata, M; Sawai, S; Tamura, N; Yagui, K | 1 |
| Aono, T; Fujita, T; Hamada, M; Hayakawa, N; Hayashi, R; Itoh, M; Kakizawa, H; Makino, M; Nagasaka, A; Nagata, M; Shinohara, R; Uchimura, K | 1 |
| Doi, T; Kato, I; Ohashi, S; Okamoto, H; Sakurai, S; Takasawa, S; Takeuchi, M; Watanabe, T; Yamagishi, S; Yamamoto, H; Yamamoto, Y; Yonekura, H | 1 |
1 trial(s) available for thiazolidines and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Aldose reductase inhibition alters nodal Na+ currents and nerve conduction in human diabetics.
Topics: Adult; Aged; Aged, 80 and over; Aldehyde Reductase; Carpal Tunnel Syndrome; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Ion Transport; Male; Median Nerve; Middle Aged; Neural Conduction; Reaction Time; Rhodanine; Sodium; Sodium Channels; Thiazolidines | 2006 |
3 other study(ies) available for thiazolidines and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization.
Topics: Aged; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Liver; Liver Diseases; Liver Transplantation; Lysophospholipids; Macrophages; Male; Mice; Middle Aged; Reperfusion Injury; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Streptozocin; Thiazolidines | 2019 |
Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor.
Topics: Adolescent; Adult; Aged; Aldehyde Reductase; Blood Glucose; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Regression Analysis; Reproducibility of Results; Rhodanine; Sorbitol; Spectrophotometry; Thiazolidines | 1998 |
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
Topics: Animals; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Female; Gene Expression Regulation; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Male; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiadiazoles; Thiazolidines | 2001 |